Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00984035 · ClinicalTrials.gov registry record
Investigation of Cisplatin-Related Kidney Toxicity
A clinical trial of Cancer, sponsored by University of Chicago.
- Completed
- Registry status
- 102
- Enrollment target
- 1
- Study location
NCT00984035 is a study of Cancer that has completed, run by University of Chicago. The registered enrollment target is 102 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00984035, a study of Cancer, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify novel biomarkers of kidney injury in patients receiving cisplatin. This study will also collect DNA for future analysis.
Conditions Studied
Interventions
- OTHER urine samples (biomarkers)
- OTHER blood samples (biomarkers)
- OTHER blood sample (DNA)
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2009-09-22 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00984035
The ClinicalTrials.gov registry entry for NCT00984035 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which urine samples (biomarkers) is the first listed.
NCT00984035 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00984035 about?
NCT00984035 is a clinical study titled "Investigation of Cisplatin-Related Kidney Toxicity". The purpose of this study is to identify novel biomarkers of kidney injury in patients receiving cisplatin. This study will also collect DNA for future analysis.
What is the current status of trial NCT00984035?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2009-09-22. Estimated completion is 2018-03.
What conditions does trial NCT00984035 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT00984035?
The interventions under investigation include: urine samples (biomarkers) (OTHER), blood samples (biomarkers) (OTHER), blood sample (DNA) (OTHER).
Who is sponsoring clinical trial NCT00984035?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00984035 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.